Can laser therapy modify the secretion of the tissue-type plasminogen activator and its inhibitor in an endothelial cell culture under hyperglycemia?

1. van den Oever IAM, Raterman HG, Nurmohamed MT, Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm 2010;2010:792393. doi:10.1155/2010/792393.10.1155/2010/792393 Search in Google Scholar

2. Donnini D, Del Terra E, Ambesi-Impiombato FS, Curcio F. New in vitro model to study high glucose-dependent endothelial dysfunctions. Biochimie 2003;85(7):701-5.10.1016/S0300-9084(03)00116-0 Search in Google Scholar

3. Tjärnlund-Wolf A, Brogren H, Lo EH, Wang X. Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases. Stroke 2012;43(10):2833-9.10.1161/STROKEAHA.111.622217371284922879095 Search in Google Scholar

4. Dai H, Yu Z, Fan X, Liu N, Yan M, Chen Z, et al. Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity. Thromb Haemost 2013;109(6):1070-8.10.1160/TH12-12-0944406632823572070 Search in Google Scholar

5. Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JCM, Hoekstra JBL. Hyperglycaemia: a prothrombotic factor? J Thromb Haemost 2010;8(8):1663-9. Search in Google Scholar

6. Galajada P, Martinka E, Kubisz P, Stasko J, Mokan M. Tissue plasminogen activator and diabetes mellitus. Vnitr Lek 1998;44(11):661-4. Search in Google Scholar

7. Geppert A, Graft S, Beckmann R, Hornykewycz S, Schuster E, Binder BR, et al. Concentration of endogenous t-PA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. Arterioscler Thromb Vasc Biol 1998;18(10):1634-42.10.1161/01.ATV.18.10.1634 Search in Google Scholar

8. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, et al. Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction. J Thromb Haemost 2011;9(8):1468-74.10.1111/j.1538-7836.2011.04377.x21624046 Search in Google Scholar

9. Thögersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998;98(21):2241-7.10.1161/01.CIR.98.21.22419826309 Search in Google Scholar

10. Harte AL, McTernan PG, McTernan CL, Smith SA, Barnett AH, Kumar S. Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes. Diabetes Obes Metab 2003;5(5):302-10.10.1046/j.1463-1326.2003.00276.x12940867 Search in Google Scholar

11. Gao X, Xing D. Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci 2009;16(1):4. doi:10.1186/1423-0127-16-4.10.1186/1423-0127-16-4264497419272168 Search in Google Scholar

12. Yanaka M, Honma T, Sato K, Shinohara N, Ito J, Tanaka Y, et al. Increased monocytic adhesion by senescence in human umbilical vein endothelial cells. Biosci Biotechnol Biochem 2011;75(6):1098-103.10.1271/bbb.10090921670520 Search in Google Scholar

13. Hendudari F, Piryaei A, Hassani SN, Darbandi H, Bayat M. Combined effects of low-level laser therapy and human bone marrow mesenchymal stem cell conditioned medium on viability of human dermal fibroblasts cultured in a high-glucose medium. Lasers Med Sci 2016;31(4):749-57.10.1007/s10103-016-1867-126984346 Search in Google Scholar

14. Vaughan DE, Rai R, Khan SS, Eren M, Ghosh AK. Plasminogen activator inhibitor-1 is a marker and a mediator of senescence. Arterioscler Thromb Vasc Biol 2017;37(8):1446-52.10.1161/ATVBAHA.117.309451584619928572158 Search in Google Scholar

15. Karu T. Mitochondrial mechanisms of photobiomodulation in context of new data about multiple roles of ATP. Photomed Laser Surg 2010;28(2):159-60.10.1089/pho.2010.278920374017 Search in Google Scholar

16. Wang X, Tian F, Soni SS, Gonzales-Lima F, Liu H. Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser. Sci Rep 2016;6:30540.10.1038/srep30540497149627484673 Search in Google Scholar

17. Kajagar BM, Godhi AS, Pandit A, Khatri S. Efficacy of low level laser therapy on wound healing in patients with chronic diabetic foot ulcers – a randomised control trial. Indian J Surg 2012;74(5):359-63.10.1007/s12262-011-0393-4347740924082586 Search in Google Scholar

18. Góralczyk K, Szymańska J, Szot K, Fisz J, Rość D. Low-level laser irradiation effect on endothelial cells under conditions of hyperglycemia. Lasers Med Sci 2016;31(5):825-31.10.1007/s10103-016-1880-4490815726861982 Search in Google Scholar

19. Gryko Ł, Gilewski M, Szymańska J, Zając A, Rość D. The concept of the set to objectification of LLLT exposure. Proceedings of SPIE: Laser Technology 2012. App Lasers 2013;8703:870302. Search in Google Scholar

20. Basso FG, Oliveira CF, Kurachi C, Hebling J, de Souza Costa CA. Biostimulatory effect of low-level laser therapy on keratinocytes in vitro. Lasers Med Sci 2013;28(2):367-74.10.1007/s10103-012-1057-822314560 Search in Google Scholar

21. Collen D, Lijnen HR. Tissue-type plasminogen activator: a historical perspective and personal account. J Thromb Haemost 2004;2(4):541-6.10.1111/j.1538-7933.2004.00645.x15102005 Search in Google Scholar

22. Gils A, Declerck PJ. Plasminogen activator inhibitor-1. Curr Med Chem 2004;11(17):2323-34.10.2174/092986704336459515379715 Search in Google Scholar

23. Yamagishi S, Nakamura K, Matsui T, Ueda S, Noda Y, Imaizumi T. Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease. Cardiovasc Ther 2008;26(1):50-8.10.1111/j.1527-3466.2007.00038.x18466420 Search in Google Scholar

24. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009;94(9):3171-82.10.1210/jc.2008-253419509100 Search in Google Scholar

25. Pandolfi A, Iacoviello L, Capani F, Vitacolonna E, Donati MB, Consoli A. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. Diabetologia 1996;39(12):1425-31.10.1007/s0012500505948960822 Search in Google Scholar

26. Zhang J, Zhang X, Li H, Cui X, Guan X, Tang K, et al. Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions. Diab Vasc Dis Res 2013;10(1):49-56.10.1177/147916411244463922561229 Search in Google Scholar

27. Chen H, Wan Y, Zhou S, Lu Y, Zhang Z, Zhang R, et al. Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence. Sci China Life Sci 2012;55(6):467-73.10.1007/s11427-012-4329-422744176 Search in Google Scholar

28. Rocha Jr AM, Vieira BJ, de Andrade LC, Aarestrup FM. Effects of low-level laser therapy on the progress of wound healing in humans: the contribution of in vitro and in vivo experimental studies. J Vasc Bras 2007;6(3):258-66.10.1590/S1677-54492007000300009 Search in Google Scholar

29. Feitosa MCP, Carvalho AFM, Feitosa VC, Coelho IM, Oliveira RA, Arisawa EAL. Effects of the low-level laser therapy (LLLT) in the process of healing diabetic foot ulcers. Acta Cir Bras 2015;30(12):852-7.10.1590/S0102-86502015012000001026735058 Search in Google Scholar

30. Silveira PC, da Silva LA, Pinho CA, De Souza PS, Ronsani MM, da Luz Scheffer D, et al. Effects of low-level laser therapy (GaAs) in an animal model of muscular damage induced by trauma. Lasers Med Sci 2013;28(2):431-6.10.1007/s10103-012-1075-622399243 Search in Google Scholar

31. Ayuk SM, Houreld NN, Abrahamse H. Effect of 660 nm visible red light on cell proliferation and viability in diabetic models in vitro under stressed conditions. Lasers Med Sci 2018;33(5):1085-93. doi: 10.1007/s10103-017-2432-2.10.1007/s10103-017-2432-229520687 Search in Google Scholar

32. Houreld N, Abrahamse H. Laser light influences cellular viability and proliferation in diabetic-wounded fibroblast cells in a dose- and wavelength-dependent manner. Lasers Med Sci 2008;23(1):11-8.10.1007/s10103-007-0445-y17361392 Search in Google Scholar

33. Wang Y, Huang YY, Wang Y, Lyu P, Hamblin MR. Photobiomodulation of human adipose-derived stem cells using 810nm and 980nm lasers operates via different mechanisms of action. Biochim Biophys Acta Gen Subj 2017;1861(2):441-9.10.1016/j.bbagen.2016.10.008519589527751953 Search in Google Scholar